Cover [Abstract] Statement [Table] Statement Document and Entity Information Stockholders' Equity Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Crypto Asset, Fair Value, Current Digital assets receivable Carrying amount as of the balance sheet date of research and development incentive receivable within one year or the operating cycle, if shorter. Research and Development Incentive Receivable, Current Research and development incentive receivable Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Operating Lease, Right-of-Use Asset Right of use assets, net Deferred Costs, Noncurrent Deferred costs Deposits Assets, Noncurrent Deposits Other Long-Term Investments Other investment Investment in SAFE Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Accrued expenses Taxes Payable, Current Income tax payable Operating Lease, Liability, Current Lease liability Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Non-current liabilities: Deferred Income Tax Liabilities, Net Deferred tax liability Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Common stock, $0.001 par value; 490,000,000 shares authorized; 93,927,528 and 83,851,051 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Stock subscription receivable Stock subscription receivable Additional Paid in Capital Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Balance at the end of the period Balance at the beginning of the period Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock par value (in dollars per share) Preferred Stock, Shares Authorized Preferred Stock, shares authorized Preferred Stock, Shares Issued Preferred stock shares issued Preferred Stock, Shares Outstanding Preferred Stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Company's common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Loss from operations Investment Income, Nonoperating Interest income Interest Expense, Nonoperating Interest expense Amount of income related to Australian research and development incentives recognized in the income statement. Research And Development Incentive Income Australian research and development incentives Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Change in fair value of embedded derivative Unrealized loss on embedded derivative Change in fair value of embedded derivative Unrealized loss on embedded derivative Foreign Currency Transaction Gain (Loss), before Tax Foreign currency loss Foreign currency loss Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Income Tax Expense (Benefit) Benefit from income taxes Net loss Net loss attributable to common stockholders Net loss Net Loss Per Share Net loss per share Earnings Per Share, Basic Basic (in dollars per share) Net loss per share attributable to common stockholders - basic Earnings Per Share, Diluted Diluted (in dollars per share) Net loss per share attributable to common stockholders - diluted Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Basic (in shares) Weighted average number of common shares outstanding - basic Weighted Average Number of Shares Outstanding, Diluted Diluted (in shares) Weighted average common shares outstanding - diluted CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Foreign currency translation adjustments Foreign currency translation adjustment Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common stock Common Stock Receivables from Stockholder [Member] Stock Subscription Receivable Additional Paid-in Capital. Additional Paid-in Capital Accumulated Other Comprehensive Income (loss) Accumulated Other Comprehensive Loss Accumulated Deficit Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to at the market offering. At The Market Offering [Member] At the Market Offering Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Shares, Outstanding Balance at the end of the period (in shares) Balance at the beginning of the period (in shares) Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Issuance of common stock upon exercise of stock options (in shares) Represents the amount of common stock issued for exercise of prefunded warrants. Stock Issued During Period, Value, Exercise of Prefunded Warrants Issuance of common stock upon exercise of prefunded warrants Represents the number of common stock issued for exercise of prefunded warrants. Stock Issued During Period, Shares, Exercise of Prefunded Warrants Issuance of common stock upon exercise of prefunded warrants (in shares) Stock Issued During Period, Value, New Issues Net proceeds Issuance of common stock through ATM sales Stock Issued During Period Shares New Issues Common stock issued Issuance of common stock through ATM sales (in shares) Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Amortization of ATM issuance costs Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Issuance of common stock upon vest of restricted stock units Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Issuance of common stock upon vest of restricted stock units (in shares) The amount of stock subscription receivable from issuance of common stock. Stock Subscription Receivable From Issuance Of Common Stock Collection of stock subscription receivable related to ATM share issuances APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Operating Lease, Right-of-Use Asset, Amortization Expense Non-cash operating lease expense Deferred Income Tax Expense (Benefit) Deferred income taxes Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets The increase (decrease) during the reporting period in amount due within one year (or one business cycle) with respect to research and development incentive receivable. Increase (Decrease) in Research and Development, Incentive Receivable Research and development incentive receivable Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses The increase (decrease) during the reporting period in lease liabilities. Increase (Decrease) in Lease Liabilities Lease liability Increase (Decrease) in Other Operating Assets Other assets Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Investments Other investment Amount of Investment Payment for Acquisition, Crypto Asset Purchases of digital assets Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Sale of Stock, Consideration Received on Transaction Net proceeds Proceeds through issuance of common stock through ATM sales, net of fees Amount of cash inflow from the collection of stock subscription receivable. Proceeds From Collection Of Stock Subscription Receivable Collection of stock subscription receivable Proceeds from Issuance of Private Placement Gross proceeds from private placement Proceeds from April 2024 Private Placement Payments of Stock Issuance Costs Payment of deferred offering costs Repayments of Short-Term Debt Principal payments of insurance financing Proceeds from Stock Options Exercised Proceeds from the exercise of stock options Net Cash Provided by (Used in) Financing Activities Net cash provided by (used in) financing activities Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Effect of exchange rate changes on cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net decrease in cash and cash equivalents Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash financing activities: Health Care Organization, Stop Loss Insurance Premium Expense Prepayment of insurance through third-party financing Nature of Business, Basis of Presentation and Liquidity Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Nature of Business, Basis of Presentation and Liquidity Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Digital Assets Receivable Crypto Asset [Text Block] Digital Assets Receivable No definition available Stock Subscription Receivable The entire disclosure pertaining to stock subscription receivable Stock Subscription Receivable [Text Block] Stock Subscription Receivable Other Investment The entire disclosure for other long-term investments. Other Long Term Investments Disclosure [Text Block] Other Investment Accrued Expenses The entire disclosure for accrued expenses. Accrued Expenses, Disclosure [Text Block] Accrued Expenses Leases Lessee, Operating Leases [Text Block] Leases Warrants Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Warrants The entire disclosure of warrants. Warrants Disclosure [Text Block] Warrants Common Stock Stockholders' Equity Note Disclosure [Text Block] Common Stock Equity Incentive Plans Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Equity Incentive Plans Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Equity Incentive Plans Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Net Loss Per Share Earnings Per Share [Text Block] Net Loss Per Share Income Taxes Income Tax Disclosure [Text Block] Income Taxes Commitments and Contingencies Other Commitments [Table] Other Commitments [Line Items] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Subsequent Events Subsequent Events [Text Block] Subsequent Events Consolidation, Policy [Policy Text Block] Principles of Consolidation Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Disclosure of accounting policy for crypto-assets. Crypto Assets Policy [Policy Text Block] Digital Assets Receivable Research and Development Expense, Policy [Policy Text Block] Research and Development Expense Disclosure of accounting policy for research and development incentive income and receivables. Research And Development Incentive Income And Receivable [Policy Text Block] Research and development incentive income and receivable Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Translation Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Disclosure of accounting policy for restructuring and related costs. Restructuring and Related Costs [Policy Text Block] Restructuring Charges Disclosure of accounting policy for costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. Deferred Offering Costs [Policy Text Block] Deferred Costs Deposit Contracts, Policy [Policy Text Block] Deposits Represents the accounting policy on warrants. Warrants [Policy Text Block] Warrants Fair Value Measurement, Policy [Policy Text Block] Fair Value of Financial Instruments Lessee, Leases [Policy Text Block] Leases Segment Reporting, Policy [Policy Text Block] Segment Information Earnings Per Share, Policy [Policy Text Block] Net Loss per Share Subsequent Events, Policy [Policy Text Block] Subsequent Events New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Tabular disclosure of the change in research and development incentive receivable. Schedule Of Change In Research And Development Incentive Receivable [Table Text Block] Schedule of change in the research and development incentive receivable Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of assets and liabilities carried at fair value in accordance with the hierarchy Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of future lease payments Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of warrants Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of stock option activity under the Equity Plans Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of RSU activity under the 2016 Plan Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Schedule of recognized stock-based compensation expense related to the issuance of stock option awards and RSUs to employees and non-employees in the condensed consolidated statements of operations Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of basic and diluted net income (loss) per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potentially anti-dilutive securities excluded from calculation of diluted net income (loss) per share Disclosure of information about organization consolidation and presentation of financial statements. Organization Consolidation And Presentation Of Financial Statements [Table] Private Placement [Member] Private Placement Counterparty Name [Axis] Repurchase Agreement Counterparty Name [Domain] Represents information pertaining to Cantor Fitzgerald & Co. Cantor Fitzgerald And Co [Member] Cantor Fitzgerald And Co Disclosure of information about nature of business, basis of presentation and liquidity. Nature of Business, Basis of Presentation and Liquidity [Line Item] Nature of Business, Basis of Presentation and Liquidity No definition available Liquidity [Abstract] Liquidity and Going Concern Value of shares issued or issuable in sale of stock transaction. Sale of Stock, Value of Shares Issued or Issuable in Transaction Value of shares issued Amount of maximum value of shares issued in sale of stock transaction. Sale of Stock, Maximum Value of Shares Issued in Transaction Aggregate offering price Additional capital Schedule of accounting policies. Summary Of Significant Accounting Policies [Table] Products and Services [Axis] Products and Services [Domain] License and Service License and Service N/A Significant Accounting Policies [Line Items] Summary of Significant Accounting Policies Crypto Asset, Fair Value [Abstract] Digital Assets Receivable Fair value of host contract of crypto asset as of the balance sheet date Crypto Asset, Host Contract, Fair Value Fair value of digital assets No definition available. Research And Development Incentive Income And Receivable [Abstract] Research and development incentive income and receivable Percent of total eligible research and development expenses incurred by the Company that are reimbursed through the Australian Government research and development incentive related to the Australian Income Tax Assessment Act 1997. Australian Research And Development Incentive Percent Expenses Reimbursed Research and development expenses reimbursed (as a percent) Amount of income related to Australian research and development incentives recognized in the income statement. Research And Development Incentive Income Expense Australian research and development incentives Represents certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred offering costs Deferred Offering Costs Noncurrent Deferred costs No definition available. Research And Development Incentive Income And Receivable [Roll Forward] Research and development incentive income and receivable Carrying amount as of the balance sheet date of research and development incentive receivable within one year or during the operating cycle, if shorter. Research and Development Incentive Receivable Balance at the end of the period Balance at the beginning of the period The amount of foreign currency gain (loss) from research And Development incentive. Research And Development incentive, Foreign Currency Translation Gain (Loss) Foreign currency translation Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Number of Positions Eliminated, Period Percent Represents the number of phases during which workforce reductions were executed as part of a restructuring plan. Restructuring and Related Cost, Reduction In Workforce, Number of Phases Restructuring and related cost, reduction in workforce, number of phases Restructuring Charges Restructuring charges Severance Costs Cash payment against the severance accrual Restructuring Reserve, Current Accrued restructuring charges Severance Lessee, Operating Lease, Discount Rate Incremental borrowing rate Number of Reportable Segments Number of Operating Segments Assets, Noncurrent [Abstract] Other Assets Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 Level 1 Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value of Financial Instruments Assets, Fair Value Disclosure [Abstract] Assets: Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Crypto Asset, Fair Value Digital assets receivable Assets, Fair Value Disclosure Total assets Number of crypto asset units purchased. Crypto Asset, Number of Units Purchased Number of crypto asset units purchased Average purchase price per unit of crypto asset. Crypto Asset, Average Purchase Price Per Unit Average purchase price per unit of crypto asset Crypto Asset, Purchase Aggregate purchase price Embedded Derivative, Fair Value of Embedded Derivative Asset Fair value of embedded derivative Disclosure of information about Stock Subscription Receivable Stock Subscription Receivable [Table] N/A Stock Subscription Receivable (Line item) Stock Subscription Receivable Cash received from stock transaction proceeds after deduction issuance costs. Sale Of Stock Consideration Received On Transaction Proceeds Net proceeds Schedule of Investments [Table] Investment, Issuer Name [Axis] Investment, Issuer Name [Domain] This member stands for Zcash Open Development Lab (ZODL). Zcash Open Development Lab [Member] ZODL Schedule of Investments [Line Items] Other Investment Debt Conversion, Converted Instrument, Amount Investment to be converted into preferred stock Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical trials. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Clinical Trials, Current Clinical trials Accrued Professional Fees, Current Professional fees Employee-related Liabilities, Current Payroll and related expenses Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] Leases Minimum period of notice of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Lessee, Operating Lease, Minimum Notice Period Lessee, operating lease, minimum notice period Amount represents addition in operating lease liability after extension of term. Operating Lease, Additional Liability Additional operating lease liability Amount represents additional right of use asset after extension of term. Operating Lease, Additional Right-of-Use Asset Additional right of use asset Operating Lease, Liability Total operating lease liabilities Lease liability Operating Lease, Cost Operating lease costs Variable Lease, Cost Cash paid for measurement of lease liabilities Lessee, Operating Lease, Liability, to be Paid, Year One 2026 Lessee, Operating Lease, Liability, Payments, Due Total Lease Payments Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents information pertaining to the warrants exercisable on 23rd January 2017. January 23 2017 Warrants [Member] January 23, 2017 Warrants Represents the information pertaining to March 2020 Pre-funded Warrants. " March 2020 Coverage Warrants [Member] March 2020 Coverage Warrants Represents information pertaining to October 2025 Pre-funded warrants. October 2025 Pre-Funded Warrants [Member] October 2025 Pre-funded warrants Represents information pertaining to october 2025 common warrants investors October 2025 Common Warrants-Investors [Member] October 2025 Common Warrants-Investors Represents information pertaining to October 2025 common warrants placement agent warrants. October 2025 Common Warrants-Placement Agent Warrants [Member] October 2025 Common Warrants-Placement Agent Warrants Represents information pertaining to October 2025 common warrants. October 2025 Common Warrants [Member] October 2025 common warrants Represents information pertaining to the 2019 warrants. Warrants2019[Member] 2019 Warrants Class of Warrant or Right, Outstanding Number of common shares issuable Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price of warrant Exercise price per share "Represents the information pertaining to March 2020 Pre-funded Warrants. " March 2020 Pre-funded Warrants [Member] March 2020 Pre-funded Warrants "Represents the information pertaining to March 2020 Pre-funded Warrants. " September 2021 Pre-funded Warrants [Member] September 2021 Pre-funded Warrants Represents the information pertaining to April 2024 pre-funded warrants. April 2024 Pre-funded Warrants [Member] April 2024 Pre-funded Warrants Number of warrants exercised during the period. Class of Warrant or Right, Warrants Exercised Warrants exercised Number of shares issued as a result of exercise of warrants. Stock Issued During Period, Shares, Warrants Exercised Stock issued during period Represents the information pertaining to January 2023 Common Stock Warrants. January 2023 Common Stock Warrants [Member] January 2023 Common Stock Warrants Represents the information pertaining to January 2023 Series X Preferred Stock Warrants. January 2023 Series X Preferred Stock Warrants [Member] January 2023 Series X Preferred Stock Warrants Class of Stock [Axis] Class of Stock [Domain] It represents the information pertaining to Series X Preferred Stock. Series X Preferred Stock [Member] Series X Preferred Shares Represents information pertaining to October 2025 Private Placement. October 2025 Private Placement [Member] October 2025 Private Placement Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrant to purchase shares of common stock Number of common shares issuable upon conversion for each share of temporary stock to be converted. Temporary Stock Convertible Conversion Ratio Conversion ratio Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of securities called by each warrant or right Common Stock exercisable Represents information pertaining to October 2025 common warrants. Placement Agent Warrants [Member] Placement agent warrants Amount of expense incurred for placement agent under October 2025 private placement. Placement Agent Expense Placement agent expense Amount of expense incurred for placement agent under October 2025 private placement which was paid in cash. Placement Agent Expense, Paid In Cash Placement agent expense paid in cash Period agreed for not to sell, transfer, pledge or otherwise dispose of warrants or underlying shares. Class Of Warrant Or Right, Transfer Of Warrants Or Underlying Shares, Restriction Period Placement agent warrants, restriction period Schedule reflecting a common stock. Common Stock [Table] Ownership [Axis] Ownership [Domain] This member stands for Winklevoss Capital. Winklevoss Capital [Member] Winklevoss Capital Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Common Stock [Line items] Common Stock Represents the number of votes that each common share is entitled to. Number of Vote on Common Shares Number of vote on common shares Dividends, Common Stock Dividend declared Shares Issued, Price Per Share Price per share (in dollars per share) Aggregate purchase price per unit of warrants along with purchase price common shares. Class Of Warrant Or Right, Aggregate Purchase Price Per Unit With Common Shares Aggregate purchase price of common warrants Per share amount of warrant issued. Warrants Issued, Price Per Warrant Warrant issued (in dollars per share) Percentage of commission on gross proceeds from sale of stock. Sale Of Stock, Percentage Of Commission On Gross Proceeds Gross proceeds from sale of shares Subsidiary, Ownership Percentage, Parent Ownership percentage Maximum number of directors on the Board of the company. Maximum Number of Directors on Board Maximum number of directors on the Board Number of business days prior notice given upon termination of Sale of stock agreement. Sale Of Stock, Termination Prior Notice, Number of Business Days Termination Prior Notice Amount of commission expense incurred at the time of sale of securities. Sale Of Stock, Commission Net of commissions Deferred Offering Costs Deferred offering costs Amount of amortization expense attributable to stock issuance costs. Amortization of Stock Issuance Costs Amortization of Stock Issuance Costs Plan Name [Axis] Plan Name [Domain] Represents information pertaining to the 2016 Equity Incentive Plan. Equity Incentive Plan 2016 [Member] 2016 Plan Represents the information pertaining to Equity Incentive Plan 2016 and 2022. EquityIncentivePlan2016and2022[Member] 2016 and 2022 Plan Represents information pertaining to the 2022 Equity Incentive Plan. 2022 Plan [Member] 2022 Plan Represents the information pertaining to 2025 Equity Incentive Plan. Equity Incentive Plan 2025 [Member] 2025 Plan Options to purchase common stock Restricted Stock Units (RSUs) [Member] Restricted stock units to purchase common stock Range [Axis] Range [Member] Minimum [Member] Minimum Maximum [Member] Maximum Weighted Average [Member] Weighted Average Income Statement Location [Axis] Income Statement Location [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding balance at the end of the period (in shares) Outstanding balance at the beginning of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Options exercisable at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Options vested and expected to vest at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Per Share Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding balance at the end of the period (in dollars per share) Outstanding balance at the beginning of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Options exercisable at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Options vested and expected to vest at end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted Average Remaining Life in Years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Options exercisable at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Options vested and expected to vest at end of the period Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Number of options or stock awards available for grant under the Plan Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Expiration period Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Unrecognized compensation cost related to non-vested stock options Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Weighted average period for recognition of compensation cost Represents the annual increase in shares authorized for issuance, effective January 1, 2018, as a percent. Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Authorized, Annual Increase, Percentage Annual increase in authorized shares (as a percent) Common Stock, Capital Shares Reserved for Future Issuance Shares reserved for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Additional shares issuable Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Company increased authorized shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Vested Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Unrecognized compensation costs related to RSUs granted to employees Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Unrecognized costs weighted-average period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding at the end Outstanding at the beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Settled by the issuance of common stock (in shares) Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Non vested, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Outstanding at end(in dollars per share) Outstanding at beginning( in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Settled by the issuance of common stock (in dollars per share) Allocated Share-based Compensation Expense Stock Based Compensation Expense Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Numerator: Net Income (Loss) Available to Common Stockholders, Basic Net loss attributable to common stockholders for basic loss per share Net Income (Loss) Available to Common Stockholders, Diluted Net loss attributable to common stockholders for diluted loss per share Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Denominator: Number of shares represents the information of weighted average number of shares outstanding exercise of pre funded warrants and penny warrants. Weighted Average Number Of Shares Outstanding Exercise Of Pre Funded Warrants And Penny Warrants Number of weighted average common shares issuable upon the exercise of the pre-funded warrants and penny warrants Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities Name [Domain] Represents warrants to purchase common stock. Warrants to purchase common stock [Member] Warrants to purchase common stock Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net Loss Per Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive securities excluded from calculation of diluted net income (loss) per share Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Represents information pertaining to license and service agreements. License and service agreements [Member] License and service agreements Supply Commitment, Remaining Minimum Amount Committed Manufacturing commitments Amount of insurance premium receivable from entity in insurance financing agreement. Health Insurance Premium Receivable Insurance premiums Percentage of annual fixed interest rate by receiving health insurance premium. Annual Fixed Interest Rate Of Insurance Premium Fixed annual interest rate (as a percent) Amount of payments of insurance premium on monthly basis during the period. Payment Of Insurance Premium Payment of insurance premium Amount of outstanding principal of the loan and accrued expenses related to the insurance premium. Outstanding Principal Of Loan Including Accrued Expenses Related To Insurance Premium Outstanding principal of loan including accrued expenses Accrued Royalties Royalties paid or accrued Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent event Subsequent Event [Line Items] Subsequent Events